NAT10 and non-small cell lung carcinoma: Furthermore, NAT10 modulates GAS5 expression and mediates its ac4C modification in non-small cell lung cancer (NSCLC), whereas GAS5 facilitates immune cell infiltration by activating the type I interferon signaling pathway [88].